"10.1371_journal.pone.0101591","plos one","2014-07-09T00:00:00Z","Emma-Jo Hayton; Annie Rose; Umar Ibrahimsa; Mariarosaria Del Sorbo; Stefania Capone; Alison Crook; Antony P Black; Lucy Dorrell; Tomáš Hanke","Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom; Okairos, Rome, Italy; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, The John Radcliffe, Oxford, United Kingdom; Nuffield Department of Medicine Research Building, University of Oxford, Oxford, United Kingdom; The Jenner Institute Laboratories, University of Oxford, Old Road Campus Research Building, Oxford, United Kingdom","Conceived and designed the experiments: TH, LD. Performed the experiments: E-JH, AR, UI, MDS, SC, AC, AB. Analyzed the data: E-JH. LD, TH. Contributed reagents/materials/analysis tools: MDS, SC. Contributed to the writing of the manuscript: TH, E-JH, LD.","The authors declare no conflict of interest except for MdS and SC, who were employees of OKAIROS AG from 2007 to 2013. Subsequently OKAIROS AG was acquired by GlaxoSmithKline (GSK), who now hold commercial rights on the work described in the manuscript. Presently MdS and SC have no financial or commercial interests and are not GSK employees. LC reports grants from MRC during the conduct of the study, and TH who reports grants from MRC and European and Developing Countries Clinical Trial Partnership obtained during the conduct of the study and is an inventor on patent WO06123256. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","07","Emma-Jo Hayton","EJH",9,TRUE,2,7,1,NA,TRUE,TRUE,TRUE,5,"2;3;4;6;9",TRUE
